Brain Imaging of Nicotinic Receptors in Alzheimer's Disease
2010

Brain Imaging of Nicotinic Receptors in Alzheimer's Disease

Sample size: 17 publication Evidence: moderate

Author Information

Author(s): Wu Jin, Ishikawa Masatomo, Zhang Jichun, Hashimoto Kenji

Primary Institution: Chiba University

Hypothesis

The two major subtypes of nicotinic acetylcholine receptors (α4β2 and α7) play an important role in the pathophysiology of Alzheimer's disease.

Conclusion

Imaging studies suggest that the availability of α4β2 and α7 nicotinic receptors is reduced in the brains of Alzheimer's disease patients, correlating with cognitive impairment.

Supporting Evidence

  • Postmortem studies showed a reduction of α4β2 subtype of nAChRs in the brains of patients with Alzheimer's disease.
  • Imaging studies indicated significant reductions of α4β2 nAChR in brain regions associated with cognitive impairment.
  • Both α4β2 and α7 nAChR availability correlated with the severity of cognitive impairment in Alzheimer's patients.

Takeaway

This study looks at how certain brain receptors related to nicotine are affected in people with Alzheimer's disease, which might help in understanding and treating the disease.

Methodology

The study discusses the use of positron emission tomography (PET) and single-photon emission computed tomography (SPECT) to visualize nicotinic receptors in the brains of Alzheimer's patients.

Limitations

The study primarily focuses on imaging techniques and may not address all aspects of Alzheimer's disease pathology.

Participant Demographics

The study included 17 patients with moderate to severe Alzheimer's disease and 6 subjects with amnestic mild cognitive impairment.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.4061/2010/548913

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication